07:00 , Apr 21, 2014 |  BC Week In Review  |  Financial News

Synta proposes private placement

Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Lexington, Mass.   Business: Cancer, Autoimmune   Date announced: 4/14/14   Type: Private placement   To be raised: Up to $5 million   Shares: 1.3 million   Price: $4.01   Shares...
08:00 , Mar 29, 2004 |  BioCentury  |  Strategy

All that Jazz . . .

All that Jazz . . . Company Raised Date Focus Investors Jazz $250.0 3/24/04 Neurology, cancer, endocrine Kohlberg Kravis Roberts; Prospect Venture Partners; Versant Ventures; Beecken Petty O'Keefe; Golden Gate Capital; Thoma Cressey Equity Partners;...
07:00 , Oct 13, 2003 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Synta Pharmaceuticals Corp. Lexington, Mass. Technology: High throughput chemical biology Disease focus: Cancer and immune disorders Clinical status: Phase I Founded: 2001 by Safi Bahcall and Lan Bo Chen Corporate partners: None University collaborators: Harvard...
08:00 , Mar 31, 2003 |  BioCentury  |  Finance

Ebb & Flow

While companies like SangStat (SANG) and MedImmune (MEDI) have managed to get multiple products on the market since their inception in 1988, Regeneron (REGN) - founded in the same year - has yet to reach...